Dipyridamole plus Aspirin: The Best Regimen for Stroke Prevention after Noncardioembolic Focal Cerebral Ischemia

Publisher： Karger

E-ISSN： 1421-9786|22|1|1-3

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.22, Iss.1, 2006-04, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anticoagulants, Aspirin and Dipyridamole in the Secondary Prevention of Cerebral Ischaemia: Which Is the Best for Which Patient?

By  

Cerebrovascular Diseases, Vol. 24, Iss. 1, 2007-11 ,pp. : 107-111

Karger

Access to resources Recommend Favorite

The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: A Randomized, Double-Blind, Controlled Trial

By  

Cerebrovascular Diseases, Vol. 31, Iss. 6, 2011-04 ,pp. : 601-613

Karger

Access to resources Recommend Favorite

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

By  

Cerebrovascular Diseases, Vol. 39, Iss. 1, 2014-12 ,pp. : 13-22

Karger

Access to resources Recommend Favorite

Addendum to Our Editorial ‘Dipyridamole plus Aspirin’

By  

Cerebrovascular Diseases, Vol. 22, Iss. 4, 2006-08 ,pp. : 317-317

Karger

Access to resources Recommend Favorite

Gamma-Hydroxybutyrate Accelerates Functional Recovery after Focal Cerebral Ischemia

By  

Cerebrovascular Diseases, Vol. 26, Iss. 4, 2008-08 ,pp. : 413-419

Karger

Access to resources Recommend Favorite